Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

West Pharmaceutical Services, Inc. Common Stock (NY:WST)

224.69 +6.11 (+2.80%)
Official Closing Price Updated: 7:00 PM EDT, Jun 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about West Pharmaceutical Services, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST
From Pomerantz LLP
Via GlobeNewswire
3 Profitable Stocks Skating on Thin Ice
A company with profits isn’t always a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential. 
Via StockStory
Topics Economy
Exposures Supply Chain
WST Class Action Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the West Pharmaceutical Services, Inc. Class Action
From Robbins LLP
Via GlobeNewswire
Earnings Scheduled For April 24, 2025
Via Benzinga
Law Offices of Howard G. Smith Encourages West Pharmaceutical Services, Inc. (WST) Investors To Inquire About Securities Fraud Class Action
From Law Offices of Howard G. Smith
Via Business Wire
WST Q1 Earnings Call: Revenue Guidance Raised, Margins Impacted by Product Mix and Tariffs
Healthcare products company West Pharmaceutical Services (NYSE:WST) announced better-than-expected revenue in Q1 CY2025, but sales were flat year on year at $698 million. The company’s full-year... 
Via StockStory
Topics World Trade
Exposures Tariff
WST INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST
From Pomerantz LLP
Via GlobeNewswire
3 Healthcare Stocks in Hot Water
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory... 
Via StockStory
Topics Economy Stocks
Exposures COVID-19 Supply Chain US Equities
WEST PHARMACEUTICAL ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against West Pharmaceutical Services, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Securities Fraud Investigation Into West Pharmaceutical Services, Inc. (WST) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
From Glancy Prongay & Murray LLP
Via Business Wire
West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
From Law Offices of Howard G. Smith
Via Business Wire
Securities Fraud Investigation Into West Pharmaceutical Services, Inc. (WST) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
From The Law Offices of Frank R. Cruz
Via Business Wire
Long-Term Shareholder Alert: If You Hold AppLovin Corporation (NASDAQ: APP); Maison Solutions, Inc. (NASDAQ: MSS); Monolithic Power Systems, Inc. (NASDAQ: MPWR); or West Pharmaceutical Services, Inc. (NYSE: WST), Contact Grabar Law Office Today
From Grabar Law Office
Via GlobeNewswire
WST INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
WST Investors Have Opportunity to Lead West Pharmaceutical Services, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services
From Faruqi & Faruqi, LLP
Via Business Wire
Labaton Keller Sucharow LLP Announces Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. and Certain of Its Executives
From Labaton Keller Sucharow LLP
Via Business Wire
1 Cash-Heavy Stock Worth Your Attention and 2 to Think Twice About
A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow. 
Via StockStory
Topics Economy
Exposures Supply Chain
3 Mid-Cap Stocks Facing Headwinds
Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from... 
Via StockStory
Topics Economy
Exposures Supply Chain
3 Dawdling Stocks Facing Headwinds
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets. 
Via StockStory
Topics Economy
Exposures Supply Chain
Repligen (RGEN) Q1 Earnings: What To Expect
Biopharma manufacturing company Repligen Corporation (NASDAQ:RGEN) will be announcing earnings results tomorrow morning. Here’s what to look for. 
Via StockStory
Topics World Trade
Exposures Tariff
West Pharmaceutical Defies Doubters: EPS Jumps, Outlook Raised Despite Tariff Drag
West Pharmaceutical topped Q1 estimates and raised 2025 guidance, citing stronger device demand and improved inventory trends across key markets. 
Via Benzinga
These S&P500 stocks are gapping in today's session
Wondering which stocks are making significant price gaps? Explore the S&P500 index on Thursday to find the gap up and gap down stocks in today's session. 
Via Chartmill
West Pharmaceutical Services (NYSE:WST) Exceeds Q1 Expectations, Stock Soars
Healthcare products company West Pharmaceutical Services (NYSE:WST) announced better-than-expected revenue in Q1 CY2025, but sales were flat year on year at $698 million. The company’s full-year... 
Via StockStory
Topics Economy
Exposures Supply Chain
Insights Ahead: West Pharmaceutical Servs's Quarterly Earnings
Via Benzinga
Wall Street Rally Extends Into Third Day: What's Driving Markets Thursday?
U.S. equities are pushing higher for a third straight session, eyeing the longest winning streak since the Trump tariff announcement on April 2, as optimism over corporate earnings and easing trade... 
Via Benzinga
Topics Government World Trade
Exposures Political Tariff
West Pharmaceutical Services Earnings: What To Look For From WST
Healthcare products company West Pharmaceutical Services (NYSE:WST) will be reporting results tomorrow before market open. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
These S&P500 stocks are moving in today's session
Stay informed about the performance of the S&P500 index one hour before the close of the markets on Monday. Uncover the top gainers and losers in today's session for valuable insights. 
Via Chartmill
What's going on in today's session: S&P500 movers
Curious about the top performers within the S&P500 index in the middle of the day on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive overview. 
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.